In contrast, transplanting siHDAC4-treated cardiac stem cells (CSC) in MI hearts improved cardiac function and enhanced CSC-derived myocardial regeneration and neovascularization, which is opposite to the effects caused by HDAC4 overexpression (Zhang et al., 2014). This evidence concerns the gene HDAC4 and myocardial infarction.